The Lbw2 locus promotes autoimmune hemolytic anemia

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3307-3314

  Scatizzi, John C ^a   Haraldsson, Maria K ^a   Pollard, K Michael ^a   Theofilopoulos, Argyrios N ^a   Kono, Dwight H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHROMOSOME 4; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE LOCUS; GLOMERULONEPHRITIS; LBW2 GENE; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; SPLENOMEGALY; SURVIVAL;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, HEMOLYTIC, CONGENITAL; ANIMALS; ASCITIC FLUID; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CHROMOSOME MAPPING; COOMBS' TEST; CROSSES, GENETIC; ERYTHROCYTES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, CONGENIC; MICE, INBRED NZB; MICE, INBRED STRAINS; SPLEEN; SPLENOMEGALY;

EID: 84859398274     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103561     Document Type: Article

References (47)

1. Quismorio, F. P. J. 2001. Other serologic abnormalities in systemic lupus erythematosus. In Dubois' Systemic Lupus Erythematosus, 6. ed. D. J. Wallace, and B. H. Hahn, eds. Williams and Wilkins, Baltimore, p. 523-545.
2. Giannouli, S., M. Voulgarelis, P. D. Ziakas, and A. G. Tzioufas. 2006. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann. Rheum. Dis. 65: 144-148. (Pubitemid 43131985)
3. Shur, P. H. 2011. Laboratory evaluation of patients with systemic lupus erythematosus. In Systemic Lupus Erythematosus, 5. ed. R. G. Lahita, G. C. Tsokos, J. P. Buyon, and T. Koike, eds. Elsevier, Amsterdam, p. 629-653.
4. Nossent, J. C., and A. J. Swaak. 1991. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q. J. Med. 80: 605-612.
5. Alger, M., D. Alarcon-Segovia, and S. J. Rivero. 1977. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J. Rheumatol. 4: 351-357.
6. Baek, S. W., M. W. Lee, H. W. Ryu, K. S. Lee, I. C. Song, H. J. Lee, H. J. Yun, S. Kim, and D. Y. Jo. 2011. Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. Korean J. Hepatol. 46: 111-117.
7. Videbaek, A. 1962. Auto-immune haemolytic anaemia in systemic lupus erythematosus. Acta Med. Scand. 171: 187-194.
8. Budman, D. R., and A. D. Steinberg. 1977. Hematologic aspects of systemic lupus erythematosus: current concepts. Ann. Intern. Med. 86: 220-229. (Pubitemid 8042804)
9. Barker, R. N., K. M. Casswell, M. E. Reid, R. J. Sokol, and C. J. Elson. 1992. Identification of autoantigens in autoimmune haemolytic anaemia by a nonradioisotope immunoprecipitation method. Br. J. Haematol. 82: 126-132.
10. Leddy, J. P., S. L. Wilkinson, G. E. Kissel, S. T. Passador, J. L. Falany, and S. I. Rosenfeld. 1994. Erythrocyte membrane proteins reactive with IgG (warmreacting) anti-red blood cell autoantibodies. II. Antibodies coprecipitating band 3 and glycophorin A. Blood 84: 650-656.
11. Kelly, J. A., K. Thompson, J. Kilpatrick, T. Lam, S. K. Nath, C. Gray-McGuire, J. Reid, B. Namjou, C. E. Aston, G. R. Bruner, et al. 2002. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia. Proc. Natl. Acad. Sci. USA 99: 11766-11771. (Pubitemid 34994473)
12. Bielschowsky, M., B. J. Helyer, and J. B. Howie. 1959. Spontaneous anemia in mice of the NZB/B1 strain. Proc. Univ. Otago Med. Sch. 37: 9-11.
13. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390. (Pubitemid 15093080)
14. de Sá Oliveira, G. G., S. Izui, C. T. Ravirajan, R. A. Mageed, P. M. Lydyard, C. J. Elson, and R. N. Barker. 1996. Diverse antigen specificity of erythrocytereactive monoclonal autoantibodies from NZB mice. Clin. Exp. Immunol. 105: 313-320. (Pubitemid 26246952)
15. Barker, R. N., G. G. de Sá Oliveira, C. J. Elson, and P. M. Lydyard. 1993. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur. J. Immunol. 23: 1723-1726. (Pubitemid 23218090)
16. Diiulio, N. A., R. L. Fairchild, and M. J. Caulfield. 1997. The anti-erythrocyte autoimmune response of NZB mice: identification of two distinct autoantigens. Immunology 91: 246-251.
17. Alanen, A., U. Pira, A. Colman, and R. M. Franklin. 1987. Mott cells: a model to study immunoglobulin secretion. Eur. J. Immunol. 17: 1573-1577. (Pubitemid 18000194)
18. Knight, J. G., and D. D. Adams. 1981. Genes determining autoimmune disease in New Zealand mice. J. Clin. Lab. Immunol. 5: 165-170. (Pubitemid 11152542)
19. Ozaki, S., H. Honda, N. Maruyama, S. Hirose, M. Hamaoki, H. Sato, and T. Shirai. 1983. Genetic regulation of erythrocyte autoantibody production in New Zealand black mice. Immunogenetics 18: 241-254. (Pubitemid 13002187)
20. Ochiai, K., S. Ozaki, A. Tanino, S. Watanabe, T. Ueno, K. Mitsui, J. Toei, Y. Inada, S. Hirose, T. Shirai, and H. Nishimura. 2000. Genetic regulation of anti-erythrocyte autoantibodies and splenomegaly in autoimmune hemolytic anemia-prone new zealand black mice. Int. Immunol. 12: 1-8. (Pubitemid 30045406)
21. Lee, N. J., R. J. Rigby, H. Gill, J. J. Boyle, L. Fossati-Jimack, B. J. Morley, and T. J. Vyse. 2004. Multiple loci are linked with anti-red blood cell antibody production in NZB mice - comparison with other phenotypes implies complex modes of action. Clin. Exp. Immunol. 138: 39-46. (Pubitemid 39279963)
22. Kikuchi, S., H. Amano, E. Amano, L. Fossati-Jimack, M. L. Santiago-Raber, T. Moll, A. Ida, B. L. Kotzin, and S. Izui. 2005. Identification of 2 major loci linked to autoimmune hemolytic anemia in NZB mice. Blood 106: 1323-1329. (Pubitemid 41129596)
23. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172. (Pubitemid 24311970)
24. Haraldsson, M. K., N. G. dela Paz, J. G. Kuan, G. S. Gilkeson, A. N. Theofilopoulos, and D. H. Kono. 2005. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J. Immunol. 174: 5065-5073.
25. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197: 777-788. (Pubitemid 36350872)
26. Toomey, C. B., D. M. Cauvi, W. C. Song, and K. M. Pollard. 2010. Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity. Immunology 131: 99-106.
27. Kina, T., K. Ikuta, E. Takayama, K. Wada, A. S. Majumdar, I. L. Weissman, and Y. Katsura. 2000. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109: 280-287. (Pubitemid 30350706)
28. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357: 77-80.
29. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S. Kumagai, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175: 71-79.
30. Murakami, M., H. Yoshioka, T. Shirai, T. Tsubata, and T. Honjo. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7: 877-882.
31. Hayakawa, K., R. R. Hardy, D. R. Parks, and L. A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218. (Pubitemid 13176184)
32. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159: 454-465. (Pubitemid 127493732)
33. Loh, C., Y. C. Cai, G. Bonventi, G. Lajoie, R. Macleod, and J. E. Wither. 2007. Dissociation of the genetic loci leading to b1a and NKT cell expansions from autoantibody production and renal disease in B6 mice with an introgressed New Zealand Black chromosome 4 interval. J. Immunol. 178: 1608-1617. (Pubitemid 46154632)
34. Loh, C., E. Pau, G. Lajoie, T. T. Li, Y. Baglaenko, Y. H. Cheung, N. H. Chang, and J. E. Wither. 2011. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice. J. Immunol. 186: 5845-5853.
35. Santiago-Raber, M. L., H. Amano, E. Amano, L. Fossati-Jimack, L. K. Swee, A. Rolink, and S. Izui. 2010. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J. Autoimmun. 34: 349-355.
36. Tortola, L., K. Yadava, M. F. Bachmann, C. Müller, J. Kisielow, and M. Kopf. 2010. IL-21 induces death of marginal zone B cells during chronic inflammation. Blood 116: 5200-5207.
37. Traggiai, E., A. Casati, M. Frascoli, S. Porcellini, M. Ponzoni, F. Sanvito, L. Leng, R. Bucala, L. Moretta, and F. Grassi. 2010. Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation. PLoS ONE 5: e11262.
38. Roy, V., G. Bonventi, Y. Cai, R. Macleod, and J. E. Wither. 2007. Immune mechanisms leading to abnormal B cell selection and activation in New Zealand Black mice. Eur. J. Immunol. 37: 2645-2656. (Pubitemid 47423632)
39. Zeumer, L., A. Sang, H. Niu, and L. Morel. 2011. Murine lupus susceptibility locus Sle2 activates DNA-reactive B cells through two sub-loci with distinct phenotypes. Genes Immun. 12: 199-207.
40. Schuster, H., T. Martin, L. Marcellin, J. C. Garaud, J. L. Pasquali, and A. S. Korganow. 2002. Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZB 3 NZW F1 mice. Lupus 11: 277-286. (Pubitemid 34627429)
41. Duan, B., B. P. Croker, and L. Morel. 2007. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab. Invest. 87: 14-28. (Pubitemid 44973650)
42. Haas, K. M., R. Watanabe, T. Matsushita, H. Nakashima, N. Ishiura, H. Okochi, M. Fujimoto, and T. F. Tedder. 2010. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 184: 4789-4800.
43. Xu, Z., B. Duan, B. P. Croker, E. K. Wakeland, and L. Morel. 2005. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J. Immunol. 175: 936-943. (Pubitemid 41094977)
44. Xu, Z., H. H. Potula, A. Vallurupalli, D. Perry, H. Baker, B. P. Croker, I. Dozmorov, and L. Morel. 2011. Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1. J. Immunol. 186: 6673-6682.
45. Xu, Z., C. M. Cuda, B. P. Croker, and L. Morel. 2011. The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice. Arthritis Rheum. 63: 764-774.
46. Kono, D. H., and A. N. Theofilopoulos. 2011. Genetics of lupus in mice. In Systemic Lupus Erythematosus, 5th. Ed. R. G. Lahita, ed. Academic Press, San Diego, p. 63-105.
47. Romagnani, S., G. Del Prete, E. Maggi, M. Chilosi, F. Caligaris-Cappio, and G. Pizzolo. 1995. CD30 and type 2 T helper (Th2) responses. J. Leukoc. Biol. 57: 726-730.